Advertisement

Advertisement

TPST Stock Latest News

Tempest Therapeutics provides update on development of TPST-2003

The FlyTempest Therapeutics provides update on development of TPST-2003

Tempest Therapeutics files to sell 2.78M shares of common stock for holders

PremiumThe Fly

Tempest Therapeutics files to sell 2.78M shares of common stock for holders

29d ago

Tempest Therapeutics files to sell 8.27M shares of common stock for holders

PremiumThe Fly

Tempest Therapeutics files to sell 8.27M shares of common stock for holders

1M ago

Tempest Therapeutics, Inc. (TPST) Q4 Earnings Cheat Sheet

PremiumPre-Earnings

Tempest Therapeutics, Inc. (TPST) Q4 Earnings Cheat Sheet

1M ago

Tempest Therapeutics Announces Private Placement Financing Agreement

PremiumCompany Announcements

Tempest Therapeutics Announces Private Placement Financing Agreement

1M ago

Tempest, Cincinnati Children’s AGCTC partner for TPST-2003 registrational study

PremiumThe FlyTempest, Cincinnati Children’s AGCTC partner for TPST-2003 registrational study

2M ago

Tempest Therapeutics Advances TPST-2003 CAR-T with Strong Data

Company Announcements

Tempest Therapeutics Advances TPST-2003 CAR-T with Strong Data

2M ago

Tempest Therapeutics announces data from REDEEM-1 Phase 1/2a trial on TPST-2003

The Fly

Tempest Therapeutics announces data from REDEEM-1 Phase 1/2a trial on TPST-2003

2M ago

Tempest Therapeutics Highlights Partner-Funded CAR-T Oncology Pipeline

PremiumCompany Announcements

Tempest Therapeutics Highlights Partner-Funded CAR-T Oncology Pipeline

3M ago

Tempest Therapeutics Overhauls Leadership and Acquires New Assets

PremiumCompany Announcements

Tempest Therapeutics Overhauls Leadership and Acquires New Assets

3M ago

Tempest Therapeutics Stockholders Extend Rights Plan and Approvals

PremiumCompany Announcements

Tempest Therapeutics Stockholders Extend Rights Plan and Approvals

3M ago

Tempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy

PremiumRatings

Tempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy

3M ago

Tempest Therapeutics upgraded to Buy from Neutral at H.C. Wainwright

PremiumThe FlyTempest Therapeutics upgraded to Buy from Neutral at H.C. Wainwright

3M ago

Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting

Company Announcements

Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting

4M ago

Tempest Therapeutics files to sell 1.17M shares of common stock for holders

The Fly

Tempest Therapeutics files to sell 1.17M shares of common stock for holders

5M ago

Tempest Therapeutics Secures $4.25M in Direct Offering

PremiumCompany Announcements

Tempest Therapeutics Secures $4.25M in Direct Offering

5M ago

Tempest Therapeutics prices 1.17M shares at $3.63 in registered direct offering

PremiumThe Fly

Tempest Therapeutics prices 1.17M shares at $3.63 in registered direct offering

5M ago

Tempest Therpeutics trading resumes

PremiumThe Fly

Tempest Therpeutics trading resumes

5M ago

Tempest Therapeutics Announces New Leadership and Acquisition

PremiumCompany Announcements

Tempest Therapeutics Announces New Leadership and Acquisition

5M ago

Tempest Therpeutics trading halted, volatility trading pause

PremiumThe FlyTempest Therpeutics trading halted, volatility trading pause

5M ago

Tempest announces acquisition of new dual-CAR T programs from Factor Bioscience

The Fly

Tempest announces acquisition of new dual-CAR T programs from Factor Bioscience

5M ago

Tempest Therapeutics Reports Q3 2025 Financial Results

Company Announcements

Tempest Therapeutics Reports Q3 2025 Financial Results

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >